Randomized, double-blind, 6-week non-inferiority study of lurasidone and risperidone for the treatment of schizophrenia-MedSci.cn

Randomized, double-blind, 6-week non-inferiority study of lurasidone and risperidone for the treatment of schizophrenia

Feng, Y; Shi, JG; Wang, LL; Zhang, X; Tan, YL; Zhao, JY; Ning, YP; Xie, SP; Liu, XJ; Liu, Q; Li, KQ; Wang, XL; Li, LH; Xu, XF; Deng, W; Luo, XY; Wang, G

Wang, G (corresponding author), Capital Med Univ, Beijing Anding Hosp, Dept Psychiat, Natl Clin Res Ctr Mental Disorders, Beijing, Peoples R China.

Abstract

Aim The aim of the present study was to evaluate the efficacy and safety of lurasidone for the treatment of Chinese schizophrenic patients. Methods Ho......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Randomized, double-blind, 6-week non-inferiority study of lurasidone and risperidone for the treatment of schizophrenia

科室

工具

服务